Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
This is the dose that produced the 24.2% body weight reduction in Phase 2 trials
Because GLP-3 (Reta) is an unapproved investigational molecule, it is not eligible for pharmacy compounding for human use
B2 Riboavin B2 Riboavin Riboavin is mainly involved in energy metabolism and helps the thyroid function properly
It is also beneficial for patients with metabolic conditions like type 2 diabetes or metabolic syndrome
Retatrutide vs Tirzepatide is mainly a comparison between an investigational triple-receptor drug and an approved dual-receptor medicine
US$ 24.53
US$ 29.27
US$ 29.96
US$ 29.69
.jpg)
